Page last updated: 2024-09-04

levofloxacin and Obesity

levofloxacin has been researched along with Obesity in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bolac, C; Brassat, S; Camus, M; Cante, V; Guillet, G; Paquier-Valette, C	1
Adams, VR; Cook, AM; Martin, C; Morehead, RS	1

Trials

1 trial(s) available for levofloxacin and Obesity

Article	Year
Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adults. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:7 Topics: Adult; Anti-Bacterial Agents; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Obesity; Ofloxacin; Young Adult	2011

Other Studies

1 other study(ies) available for levofloxacin and Obesity

Article	Year
[Endogenous endophthalmitis as a complication in erysipelas]. Annales de dermatologie et de venereologie, 2013, Volume: 140, Issue:11 Topics: Antifungal Agents; Bacteremia; Ceftazidime; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Therapy, Combination; Endophthalmitis; Erysipelas; Eye Infections, Bacterial; Humans; Imipenem; Intertrigo; Leg; Levofloxacin; Male; Middle Aged; Obesity; Streptococcus agalactiae; Uveitis, Anterior; Vancomycin	2013

Article

Year

[Endogenous endophthalmitis as a complication in erysipelas].

Annales de dermatologie et de venereologie, 2013, Volume: 140, Issue:11

Topics: Antifungal Agents; Bacteremia; Ceftazidime; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Therapy, Combination; Endophthalmitis; Erysipelas; Eye Infections, Bacterial; Humans; Imipenem; Intertrigo; Leg; Levofloxacin; Male; Middle Aged; Obesity; Streptococcus agalactiae; Uveitis, Anterior; Vancomycin

2013